Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.2K Buy
+20,200
New +$38K ﹤0.01% 12863
2024
Q1
Sell
-18,100
Closed -$29.5K 12686
2023
Q4
$29.5K Sell
18,100
-43,700
-71% -$74.9K ﹤0.01% 11884
2023
Q3
$184K Sell
61,800
-55,400
-47% -$211K ﹤0.01% 10319
2023
Q2
$523K Buy
+117,200
New +$525K ﹤0.01% 8206
2022
Q1
Sell
-254,200
Closed -$1.21M 13445
2021
Q4
$1.21M Buy
254,200
+155,600
+158% +$626K ﹤0.01% 6779
2021
Q3
$255K Buy
98,600
+87,900
+821% +$232K ﹤0.01% 10969
2021
Q2
$32K Buy
+10,700
New +$35.5K ﹤0.01% 12379
2021
Q1
Sell
-47,600
Closed -$239K 12498
2020
Q4
$239K Sell
47,600
-12,000
-20% -$54K ﹤0.01% 9740
2020
Q3
$254K Buy
+59,600
New +$274K ﹤0.01% 9034

Other funds holding IFRX

Jeff Yass's IFRX Position: Q2 2026 in Review

Jeff Yass reduced its InflaRx (IFRX) stake by 45% in Q2 2026, selling an estimated $64.5K and leaving 42,784 shares worth $95.8K. The position accounts for ﹤0.01% of the portfolio, ranked #12526.

Jeff Yass first reported a position in IFRX in Q2 2020 and has held it in 20 quarters since. The position peaked at $795K in Q2 2023. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • Jeff Yass held 42,784 shares of InflaRx worth $95.8K as of Q2 2026.
  • Jeff Yass sold 34,330 InflaRx shares in Q2 2026, an estimated $64.5K.
  • InflaRx made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12526 holding.
  • Jeff Yass first reported a position in InflaRx in Q2 2020 and has held it in 20 quarters since.
  • Jeff Yass's InflaRx position peaked at $795K in Q2 2023.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.